20 More States Join Generic Drug-Pricing Antitrust Action
Forty states are now bringing antitrust claims against six generic-drug makers including Heritage, Mylan and Teva, alleging they conspired to fix the prices of an antibiotic and a diabetes medication, according...To view the full article, register now.
Already a subscriber? Click here to view full article